A Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects with Type 2 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL

Enrollment

179

Participants

Timeline

Start Date

August 11, 2023

Primary Completion Date

July 13, 2024

Study Completion Date

August 8, 2024

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

GZR4 Injection

GZR4 injection s.c., once-weekly, treat-to-target dose

DRUG

Insulin Degludec

Insulin Degludec s.c., once-daily, treat-to-target dose

Trial Locations (8)

Study Site 07, Wuhan

Study Site 06, Changzhou

Study Site 08, Jinan

Study Site 04, Zibo

Study Site 03, Xi’an

Study Site 02, Beijing

Study Site 05, Beijing

Study Site 01, Tianjin